查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
組合藥物診斷市場，按產品類型、按應用、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1397092

組合藥物診斷市場，按產品類型、按應用、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Combination Drugs Diagnostic Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年，組合藥物診斷市場規模為 1,743.53 萬美元，2023 年至 2030 年複合CAGR為 9.2%。

組合藥物診斷市場-市場動態

預計市場成長將由老年人數量的增加和診斷技術的進步推動。

人口老化需要更全面的醫療保健解決方案，解決這個問題的一種方法是透過結合診斷功能的組合藥物。這些藥物提供了管理老年人健康的整體方法。世界衛生組織預測，到2030年，全球每6人中就有1人年齡在60歲或以上，導致60歲以上人口從2020年的10億增加到14億。診斷學的進步可以及早發現疾病和病症，從而能夠及時干涉並在疾病的最早階段開始聯合藥物治療。然而，隨著遠距醫生預約、患者監護和遠距醫療服務的採用，COVID-19 大流行也導致了這一成長。智慧型手機用戶數量不斷增加，目前已超過 30 億，預計到 2023 年將超過 40 億，進一步推動了醫療保健應用程式的普及。此外，醫療技術統計數據表明，目前有五分之一的美國人使用健身追蹤器或智慧手錶，預計到2025 年這一數字將增加20%。醫療技術和藥物開發的這些進步為創造創新組合藥物提供了機會。然而，制定包含診斷成分的組合藥物的報銷政策可能會帶來挑戰。

組合藥物診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球組合藥物診斷市場在預測期內（2023-2030 年）每年將以 9.2% 左右的CAGR成長

由於可支配收入的增加和對組合藥物認知的提高，預計組合藥物診斷行業將大幅成長。

根據產品類型細分，預計抗菌導管將在 2022 年佔據最大市場佔有率

從應用細分來看，傳染病是2022年的主導類型

按地區分類，北美是 2022 年的主要收入來源

組合藥物診斷市場-細分分析：

全球組合藥物診斷市場根據產品類型、應用和地區進行細分。

市場依產品類型分為三類：超音波、抗菌導管、心血管導管、泌尿導管、血氧測定導管、骨移植替代品、Porfimer鈉和類固醇、洗脫電極。目前市場以抗菌導管為主。然而，提供診斷、合併藥物治療和抗菌導管等綜合解決方案的公司或許能夠解決醫療保健中感染預防的複雜問題並抓住潛在機會。

根據應用，市場分為兩類：傳染病、心血管疾病、精神疾病和呼吸系統疾病。市場大程度受傳染病的影響。事實證明，藥物和診斷的結合是傳染病領域的關鍵因素。這種綜合方法有助於制定更準確、更有針對性的治療計劃，同時考慮到病原體的獨特特徵和個別患者的反應。

組合藥物診斷市場 - 地理洞察

從地理來看，組合藥物診斷市場遍佈北美、拉丁美洲、歐洲、亞太地區、中東和非洲等多個地區。這些地區根據參與商業活動的國家進一步分類。預計組合藥物診斷市場的成長將由北美主導，這主要是由於研發（R＆D）業務投資的增加。北美，尤其是美國，被公認為全球製藥和生物技術研發中心。對研發業務的大量投資有助於開發包含診斷成分的創新組合藥物。根據美國國家科學基金會下屬的國家科學與工程統計中心 (NCSES) 的數據，2020 年美國研發活動總支出達到 7,170 億美元。由於盛行率上升，歐洲佔據第二大市場佔有率癌症、心臟病和糖尿病等慢性疾病。

組合藥物診斷市場-競爭格局：

組合藥物診斷的市場格局一直在動態變化，許多公司為指導組合藥物治療的診斷工具的進步和商業化做出了貢獻。製造商積極參與開發支持聯合藥物療法的診斷方法。在臨床環境中引入的新一代標靶治療的很大一部分要求患者接受治療適應症所需的基本測試，即伴隨診斷。此外，還有一些稱為補充診斷的測試可以支持治療決策，但在處方前並不是必要的。製藥公司開發新藥方式的這種轉變導致尋求監管部門批准的藥物診斷組合數量顯著增加。個人化醫療的日益成長的趨勢，即根據患者個別特徵制定治療決策，是組合藥物診斷市場的主要驅動力。持續的技術進步，特別是診斷技術和成像技術的進步，在塑造競爭格​​局方面發揮著至關重要的作用。

最近的發展：

羅氏的 Columvi 已獲得 FDA 批准為瀰漫性大 B 細胞淋巴瘤（一种血癌）的第三線治療藥物。這種新藥現在將與艾伯維 (AbbVie) 的 Epkinly 競爭，後者最近被批准用於相同的病症。羅氏新藥的批准為患者提供了另一種治療選擇。

目錄

第 1 章：組合藥物診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的組合藥物診斷市場片段
    • 組合藥物診斷市場片段（按應用）
    • 按國家/地區分類的組合藥物診斷市場片段
    • 按地區分類的組合藥物診斷市場片段
  • 競爭洞察

第 3 章：組合藥物診斷主要市場趨勢

  • 組合藥物診斷市場促進因素
    • 市場促進因素的影響分析
  • 組合藥物診斷市場限制
    • 市場限制影響分析
  • 組合藥物診斷市場機會
  • 組合藥物診斷市場未來趨勢

第 4 章：組合藥物診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：組合藥物診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：組合藥物診斷市場格局

  • 2022 年組合藥物診斷市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：組合藥物診斷市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 超音波
    • 抗菌導管
    • 心血管導管
    • 泌尿導管
    • 血氧測定導管
    • 骨移植替代品
    • 卟啉鈉和類固醇
    • 洗脫電極

第 8 章：組合藥物診斷市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 傳染性疾病
    • 心血管疾病
    • 精神疾病
    • 呼吸系統疾病

第 9 章：組合藥物診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美組合藥物診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲組合藥物診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區組合藥物診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲組合藥物診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲組合藥物診斷主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 組合藥物診斷產業

  • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • Roche
    • Novartis International AG
    • GlaxoSmithKline plc.
    • Pfizer Inc.
    • Sanofi
    • Bristol-Myers Squibb Company
    • Johnson & Johnson
    • Eli Lilly and Company
    • Gilead Sciences, Inc.

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1863

REPORT HIGHLIGHT

The combination medications and diagnostic tools plays a crucial role in modern healthcare, particularly in the realm of personalized medicine and targeted therapies. A combination product refers to a therapeutic or diagnostic product that combines drugs, medical devices, and/or biological products. Such products typically involve at least two of these categories and sometimes encompass all three. Common examples include traditional drug-device combinations, such as a syringe pre-filled with medication, as well as co-packaged or kitted products, like a first-aid kit containing bandages and pain-relieving medications. In the healthcare field, diagnostics pertain to the identification of the nature and cause of a disease or condition. Diagnostic tools encompass various techniques, including imaging, laboratory tests, and other medical assessments.

Combination Drugs Diagnostic Market- Market Dynamics

The market growth is anticipated to be driven by the increasing number of elderly individuals and advancements in diagnostic techniques.

Aging populations necessitate more comprehensive healthcare solutions, and one approach to address this is through combination drugs that incorporate diagnostic capabilities. These drugs offer a holistic approach to managing the health of elderly individuals. The World Health Organization predicts that by 2030, 1 in 6 people worldwide will be aged 60 years or over, resulting in an increase in the population aged 60 years and over from 1 billion in 2020 to 1.4 billion. The advancement of diagnostics allows for the early detection of diseases and conditions, enabling timely intervention and the initiation of combination drug therapies at the earliest stages of illnesses. However, the COVID-19 pandemic has also contributed to this rise, with the adoption of remote doctor's appointments, patient monitoring, and telehealth services. The increasing number of smartphone users, which has surpassed 3 billion today and is projected to exceed 4 billion by 2023, has further boosted the popularity of healthcare apps. Additionally, medical technology statistics indicate that 1 in 5 Americans currently utilize fitness trackers or smartwatches, a number expected to grow by 20% by 2025. These advancements in medical technology and drug development present opportunities for the creation of innovative combination drugs. However, establishing reimbursement policies for combination drugs that include diagnostic components can pose a challenge.

Combination Drugs Diagnostic Market- Key Insights

  • As per the analysis shared by our research analyst, the global Combination Drugs Diagnostic market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)
  • The Combination Drugs Diagnostic sector is expected to experience substantial growth as a result of an increase in disposable income and greater awareness of combination drugs.
  • Based on product type segmentation, Antimicrobial catheters were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Infectious Diseases was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Combination Drugs Diagnostic Market- Segmentation Analysis:

The Global Combination Drugs Diagnostic Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into three categories based on product type: Ultrasound, Antimicrobial catheters, Cardiovascular catheters, urological catheters, Oximetry catheters, Bone graft substitutes, Porfimer sodium & steroid and Eluting electrodes. The market is currently dominated by antimicrobial catheters. However, companies that provide comprehensive solutions, including diagnostics, combination drug therapies, and antimicrobial catheters, may be able to tackle the intricate issues of infection prevention in healthcare and seize potential opportunities.

The market is divided into two categories based on application: Infectious Diseases, Cardiovascular Diseases, Psychiatric Disorders, and Respiratory Disorders. The market is largely influenced by Infectious Diseases. The amalgamation of drugs and diagnostics is proving to be a crucial factor in the realm of infectious diseases. This comprehensive approach facilitates more accurate and focused treatment plans, taking into account the unique features of pathogens and individual patient reactions.

Combination Drugs Diagnostic Market- Geographical Insights

Geographically, the market for Combination Drugs Diagnostics is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The growth of the Combination Drugs Diagnostic market is expected to be dominated by North America, primarily due to the increasing investments in research and development (R&D) operations. North America, especially the United States, is recognized as a global center for pharmaceutical and biotechnology R&D. The substantial investments in R&D operations contribute to the development of innovative combination drugs that incorporate diagnostic components. According to the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation, the total expenditure on R&D activities in the United States reached USD 717.0 billion in 2020. Europe holds the second-largest market share, driven by the rising prevalence of chronic diseases such as cancer, heart disease, and diabetes.

Combination Drugs Diagnostic Market- Competitive Landscape:

The landscape of the market for combination drug diagnostics has been dynamic, with numerous companies contributing to the advancement and commercialization of diagnostic tools for guiding combination drug therapies. The manufacturers are actively involved in developing diagnostics that support combination drug therapies. A significant portion of the new generation of targeted therapies being introduced in clinical settings require patients to undergo essential tests that are necessary for the therapy's indication, known as companion diagnostics. Additionally, there are tests known as complementary diagnostics that support treatment decisions but are not essential prior to prescription. This shift in the way pharmaceutical companies develop new medicines has led to a significant increase in the number of drug-diagnostic combinations seeking regulatory approval. The growing trend towards personalized medicine, where treatment decisions are tailored to individual patient characteristics, is a major driving force in the combination drugs diagnostic market. Ongoing technological advancements, particularly in diagnostic technologies and imaging, play a crucial role in shaping the competitive landscape.

Recent Developments:

Roche's Columvi has been granted FDA approval as a third-line treatment for diffuse large B-cell lymphoma, a type of blood cancer. This new drug will now compete with AbbVie's Epkinly, which was recently approved for the same condition. The approval of Roche's new drug provides patients with another therapeutic option.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche
  • Novartis International AG
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • Eli Lilly and Company
  • Gilead Sciences, Inc.

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY PRODUCT TYPE

  • Ultrasound
  • Antimicrobial catheters
  • Cardiovascular catheters
  • Urological catheters
  • Oximetry catheters
  • Bone graft substitutes
  • Porfimer sodium & steroid
  • Eluting electrodes

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY APPLICATION

  • Infectious Diseases
  • Cardiovascular Diseases
  • Psychiatric Disorders
  • Respiratory Disorders

GLOBAL COMBINATION DRUGS DIAGNOSTIC MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Combination Drugs Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Combination Drugs Diagnostic Market Snippet by Product Type
    • 2.1.2. Combination Drugs Diagnostic Market Snippet by Application
    • 2.1.3. Combination Drugs Diagnostic Market Snippet by Country
    • 2.1.4. Combination Drugs Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Combination Drugs Diagnostic Key Market Trends

  • 3.1. Combination Drugs Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Combination Drugs Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Combination Drugs Diagnostic Market Opportunities
  • 3.4. Combination Drugs Diagnostic Market Future Trends

4. Combination Drugs Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Combination Drugs Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Combination Drugs Diagnostic Market Landscape

  • 6.1. Combination Drugs Diagnostic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Combination Drugs Diagnostic Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Ultrasound
    • 7.1.3. Antimicrobial catheters
    • 7.1.4. Cardiovascular catheters
    • 7.1.5. Urological catheters
    • 7.1.6. Oximetry catheters
    • 7.1.7. Bone graft substitutes
    • 7.1.8. Porfimer sodium & steroid
    • 7.1.9. Eluting electrodes

8. Combination Drugs Diagnostic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Psychiatric Disorders
    • 8.1.5. Respiratory Disorders

9. Combination Drugs Diagnostic Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Combination Drugs Diagnostic Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Combination Drugs Diagnostic Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Combination Drugs Diagnostic Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Combination Drugs Diagnostic Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Combination Drugs Diagnostic Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Combination Drugs Diagnostic Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
    • 10.2.2. Roche
    • 10.2.3. Novartis International AG
    • 10.2.4. GlaxoSmithKline plc.
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Sanofi
    • 10.2.7. Bristol-Myers Squibb Company
    • 10.2.8. Johnson & Johnson
    • 10.2.9. Eli Lilly and Company
    • 10.2.10. Gilead Sciences, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Combination Drugs Diagnostic Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Combination Drugs Diagnostic Market, by Product Type 2018-2030 (USD Million)
  • TABLE Combination Drugs Diagnostic Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Combination Drugs Diagnostic Market, by Application 2018-2030 (USD Million)
  • TABLE Combination Drugs Diagnostic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Combination Drugs Diagnostic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Combination Drugs Diagnostic Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Combination Drugs Diagnostic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Europe Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Asia Pacific Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Latin America Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Germany Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE India Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Brazil Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Combination Drugs Diagnostic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Combination Drugs Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)